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Background:The trends in the IHDmortality rates varywidely across countries, reﬂecting theheterogeneity in the
variation of the exposure to the main risk factors and in the access to different management strategies among
settings. We aimed to identify model-based patterns in the time trends in IHD mortality in 50 countries from
the ﬁve continents, between 1980 and 2010.
Methods and results:Mixedmodelswere used to identify time trends in age-standardizedmortality rates (ASMR)
(age group 35+ years; world standard population), all including random terms for intercept, slope, quadratic
and cubic. Model-based clustering was used to identify the patterns.
We identiﬁed ﬁve main patterns of IHD mortality trends in the last three decades, similar for men and women.
Pattern 1 had the highest ASMR and pattern 2 exhibited the most pronounced decrease in ASMR during the
entire studyperiod. Pattern 3was characterized by an initial increase inASMR, followed by a sharp decline. Coun-
tries in pattern 4 had the lowest ASMR throughout the study period. It was further divided into patterns 4a
(consistent decrease in ASMR throughout the period of analysis) and 4b (less pronounced declines and highest
rates observed mostly between 1996 and 2004). There was no correspondence between the geographic or
economical grouping of the analyzed countries and the patterns found in this study.
Conclusions:Our study yielded a new framework for the description, interpretation and prediction of IHDmortal-
ity trends worldwide.© 2013 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Worldwide, cardiovascular diseases (CVD) were responsible for
17.3 million deaths in 2008, corresponding to 32% of all deaths in
women and 27% in men. Ischemic heart disease (IHD) and cerebrovas-
cular diseases are responsible for approximately two thirds of the CVD
deaths [1], with IHD accounting for 7.3 million deaths yearly. Approxi-
mately four ﬁfths of these occur in low and middle income countries
(LMIC) [2] and IHD remains the leading cause of death in high income
settings [1,3], despite the downward trends observed in the last decades
[4].
This decline results primarily from changes in exposure tomajor risk
factors, including decreases in tobacco consumption [5,6] and physical
inactivity [7,8], lower blood pressure [9,10] and serum cholesterol
[10,11] in the general population, and a better control of dyslipidaemia
[8] and hypertension [12–15], as well as from the increasing access tologia Clínica, Medicina Preditiva
de do Porto, Al. Prof. Hernâni
52; fax: +351 22551 3653.
eliability and freedom from bias
td. All rights reserved.earlier and more effective management of acute coronary syndromes
[16,17] and uptake of long-term secondary prevention [14,18].
The trends in the IHD mortality rates vary widely across countries,
reﬂecting the heterogeneity in the variation of the exposure to the
main risk factors and in the access to different management strategies
among settings. Previous attempts to describe worldwide patterns of
IHD mortality trends relied on grouping the countries mostly based on
geographical criteria or socio-economic characteristics [19,20]. Howev-
er, model-based clustering may allow the deﬁnition of more homoge-
neous groups of countries, accounting for the mortality rates at the
onset of the observation period, as well as the magnitude and slope of
its variation, with no a priori constraints.
This study aimed to identify patterns of time trends in IHDmortality
across countries, using a model-based approach.2. Methods
All European countries, high-income non-European countries and the leading emerg-
ing economies jointly referred to as BRICS, as deﬁned by the United Nations (UN) [21],
with available data were eligible for the present study.
We abstracted death certiﬁcation data from the World Health Organization (WHO)
database [22], for the period between 1980 (or the ﬁrst calendar year with available
data since 1980) and 2010 (or themost recent data available) for each country. Countries
with no data available in electronic support (India) or having data available for less than
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Montenegro) were excluded. From China we considered two sets of data: estimates for
the mainland country, based on samples of less than 10% of the population, and speciﬁc
data from the Hong Kong Special Administrative Region (SAR).
Between 1980 and 2010 three different revisions of the International Classiﬁcation of
Diseases (ICD)were used to classify the causes of death [23–25].We extracted thenumber
of deaths due to IHD, corresponding to the codes A083 (ICD-8), B27 (ICD-9) or I20-I25
(ICD-10) [22]. The deaths with no information regarding sex were equally distributed by
men and women.
Mid-year estimates of the resident population were obtained from the 2010 revision
of UN World Prospects Population [21], even when mortality data referred to less than
90% of the country population. The latter applies to Albania (70.8%), Brazil (79.7%), Repub-
lic of Moldova (83.2%), Serbia (83.1%), South Africa (76.9%) and The Former Yugoslav Re-
public (TFYR) of Macedonia (89.2%). The population estimates for China were obtained
from the WHO database [22].
Sex-speciﬁc and age-standardized mortality rates (ASMR) were computed through
the direct method, using the world standard population [26] as reference. These data
were available for 38 European, and eight non-European countries, namely Australia,
Canada, Japan, New Zealand and United States of America (USA), Brazil, China, and
South Africa (Fig. 1). Model-based patterns were deﬁned using the ASMR referring to
the ages 35+, separately for men and women.
Mixed models, including random terms by country for the intercept, slope, quadratic
and cubic terms, were used to describe the time trends in the ASMR. The rates in the years
withmissing data, between 1980 and 2010, were estimated by thesemodels. Both the ob-
servedmortality rates and themodel predictions are presented in Appendices 1 and 2.We
excluded from further analyses the data referring to Belarus, Republic of Moldova, Russia
and Ukraine, because for these countries the models yielded coefﬁcients over three times
the interquartile range above or below themedian of all countries, for the quadratic and/or
cubic terms, formen and/orwomen (Fig. 1). Croatiawas also excluded because no reliable
estimation of ASMR in the years withmissing data could be obtainedwith these relatively
simple models (Fig. 1 and Appendices 1 and 2).
Model-based clustering was used to identify the patterns in the IHDmortality trends,
using the ASMR estimated for the period 1980–2010. In this method, the clusters are con-
sidered to be ellipsoidal, centered at themeans, and the covariances determine their other
geometric features. Characteristics (orientation, volume and shape) of distributions areFig. 1. Flowchart of the model-based approach used to identify ischemic heart disease mo
BEL=Belgium; BGR=Bulgaria; BIH=Bosnia and Herzegovina; BLR=Belarus; BRA=B
Republic; DEU=Germany; DNK=Denmark; ESP=Spain; EST=Estonia; FIN=Finland; FR
istrative Region; HRV=Croatia; HUN=Hungary; IND=India; IRL=Ireland; ISL=Iceland
Republic of Moldova; MKD=The Former Yugoslav Republic of Macedonia; MLT=Malta;
Poland; PRT=Portugal; ROM=Romania; RUS=Russia; SRB=Serbia; SVK=Slovakia;
ZAF=South Africa.estimated from the data, and can be allowed to vary between clusters, or constrained to
be the same for all clusters. The most appropriate models were considered those allowing
for themost homogeneous grouping of the countries regarding their patterns of variation,
as assessed by visual inspection of the country-speciﬁc trends, selected among those with
the lowest Bayesian Information Criterion (BIC) (Appendix 3).
The reliability of the model-based clustering was evaluated by tenfold cross val-
idation [27]. The sample was divided in ten partitions, and each of the subsets of nine
out of ten partitions was used to ﬁt a different model. The agreement between the
predictions from these models and those from the model obtained with the complete
dataset was calculated; the overall kappa coefﬁcient was estimated by the mean of
the coefﬁcients referring to the agreement between each of the ten subset models
and the full model.
The clusters corresponding to homogenous groups of countries regarding the trends
in ASMR were further divided according to the gross national income, Atlas method, per
capita (GNI) [28] in 1995 (the midpoint of the period under analysis) to increase the
homogeneity of the patterns. For Serbia and Hong Kong SAR we used the GNI in 1999,
for Estonia, Ireland and Czech Republic we used de GNI in 2002, as these were the ﬁrst
years with available data for these countries.
Data analyses were conducted using the software R 2.14.1.
3. Results
We identiﬁed four patterns of variation in IHD mortality, hereafter
referred to as patterns 1 to 4 (Figs. 1 and 2). The reliability of the
model-based clustering was very good, as shown by the agreement
between each of the ten subset models and the full model (men:
kappa=0.83; women: kappa=0.94).
Amongmen, despite the heterogeneous GNI values across the coun-
tries included in each pattern, all those included in pattern 2were above
the World Bank threshold to deﬁne upper middle income countries
(UMIC) (3035 USD in 1995). Pattern 4 included 11 high income coun-
tries (HIC), two UMIC, two low income countries (LIC) and two LMICrtality patterns for men and women. ALB=Albania; AUS=Austria; AUT=Australia;
razil; CAN=Canada; CHE=Switzerland; CHN=China; CYP=Cyprus; CZE=Czech
A=France; GBR=United Kingdom; GRC=Greece; HKG=Hong Kong Special Admin-
; ITA=Italy; JPN=Japan; LTU=Lithuania; LUX=Luxembourg; LVA=Latvia; MDA=
MNE=Montenegro; NLD=Netherlands; NOR=Norway; NZL=New Zealand; POL=
SVN=Slovenia; SWE=Sweden; UKR=Ukraine; USA=United States of America;
Fig. 2. Trends in age-standardized (direct method, world standard population) ischemic heart disease mortality rates for ages 35+ years for each pattern identiﬁed in men and women.
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including four LIC or LMIC. Pattern 1 had two LMIC and only one UMIC
while pattern 3 included six UMIC or HIC and only two LMIC; these
patterns were not further divided (Fig. 3). Among women, there was a
similar relation between the patterns and the countries' GNI; pattern
4 was also divided into 4a including 16 UMIC or HIC and 4b including
two LIC and two LMIC. Pattern 1 included two LMIC and one UMIC
and patterns 2 and 3 included only one LMIC; these patterns were not
further divided.
Pattern 1 is characterized by the highest ASMR throughout the peri-
od of analysis, with a pronounced decline only in its second half, both in
men and women (Fig. 2). It includes only northern European countries
(Figs. 2 and 4).
Pattern 2 includes essentially UMIC and HIC, from different regions.
It is characterized by high ASMR in 1980, though nearly half the ob-
served for pattern 1, that declined steeply throughout the whole period
and are among the lowest in 2010 (Figs. 2 and 4).
Among men, pattern 3 includes countries from eastern, southern
and western Europe, while in women it included only eastern
European countries. The highest ASMR were observed mostlyFig. 3. Gross national income (Atlas method) pbetween 1999 and 2005, and in 2010 were similar to the observed
in pattern 1 (Table 1).
Most of the countries included in pattern 4a, as well as its general
characteristics, were the same among men and women. It includes
mostly southern and western European countries, as well as Japan,
Hong Kong SAR, South Africa and Brazil. The ASMR were among the
lowest and declined throughout the whole period under analysis,
though more steeply in its second half. Pattern 4b includes only south-
ern European and China (mainland); the rates are not substantially dif-
ferent from the observed for pattern 4a, though the decline is less
pronounced and the highest rates are observed mostly between 1996
and 2004 (Fig. 2 and Table 1).4. Discussion
We identiﬁed ﬁve main patterns of IHD mortality trends in the last
three decades. The clusters deﬁned with this model-based approach
are substantially different from those obtained using only geographical
or economic criteria, and these results provide a new framework for theer capita, by pattern, in men and women.
Fig. 4. Countries included in each pattern, by geographic region, in men and women.
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worldwide.
The interpretation of the trends in IHD mortality requires the under-
standing of the variation in the main determinants of its incidence and
survival. Models [33] developed to explain the changes in IHD mortality
rates observed in speciﬁc settings, through the use of standardized
methods to account for the impact of variables thought to inﬂuence coro-
nary heart disease mortality (including exposure to the main risk factors,
and uptake of treatment, combined with demographic information) may
provide valuable data to interpret our ﬁndings.
For seven countries of pattern 2, namely England andWales, Finland,
Iceland, Ireland, New Zealand, Sweden, and USA, we obtained data based
on the framework of analysis of the IMPACT model [7,18,34–38]. Despite
the heterogeneity regarding the periods of analysis (mostly between the
1980s and the ﬁrst years after 2000, except for 1982–1993 in New
Zealand and 1994–2002 in Sweden), the reductions in the exposure to
the major risk factors explain approximately half of the decline in IHD
mortality in most of these settings, though the estimate for Iceland was
73% and ranged between 44% and 58% in the remaining countries. The
contribution of the variation in the exposure to speciﬁc risk factors was
muchmore heterogeneous: England andWales had the highest percent-
age of reduction attributable to smoking (48%) and the lowest attribut-
able to serum total cholesterol levels (10%), while the inverse was
observed for Sweden (the percentages were 9% and 39%, respectively);
the estimates for blood pressure ranged from 6% in Ireland to 22%
Iceland. No substantial gender differences were observed in risk factor
trends, which is in accordance with our observation of similar patterns
of IHD mortality trends in men and women.
Medical and surgical treatments explained from 23% to 49% of the
decrease in IHD mortality in Finland and Ireland, respectively. Despite
the large differences between countries regarding the contribution of
speciﬁc treatments, secondary prevention had the largest contribution
to the decrease in most settings, though ranging from 6% in Finland to
18% in Ireland, followed by the treatment for heart failure (range: 2%–
14%, in Finland and Ireland, respectively) and the initial treatment of
acute myocardial infarction (range: 4%–12%, in Finland and New
Zealand, respectively). These results show that despite thehomogeneityof the patterns of variation in IHD mortality, the factors that determine
such trends seem to vary substantially across settings, showing that
similar effects on the mortality rates may be achieved through different
paths, supporting the potential for further reduction in the burden of
IHD through more comprehensive actions for its prevention and con-
trol. Published reports providing IMPACT model estimates were avail-
able also for Italy and Spain (pattern 4a), for the periods 1980–2000
and 1988 to 2005, respectively [39,40]. The decrease inmortality attrib-
utable to risk factors (55% in Italy, 50% in Spain) was mainly due to the
decrease in serum total cholesterol levels (31% in Spain) and blood pres-
sure (25% in Italy). The variation in the exposure to smoking had a sub-
stantially different impact in Spain (16%) and Italy (4%). Regarding the
impact of medical and surgical treatments, the estimates were more
similar and secondary prevention still had the largest contribution to
the decrease (16% in Italy and 10% in Spain).
In countries of pattern 1, the high IHD mortality is consistent with
the also high levels of exposure to tobacco smoking and use of alcohol
[41,42], as well as poor control of hypertension, despite favorable
changes in hypertension awareness and treatment [43]. Pattern 3 in-
cludes countries that experienced socioeconomic changes during the
transition to a market economy in the 1990s; this applies to countries
such as Poland, Romania or Hungary, after the communist era [44,45].
Countries with increasing trends of smoking, obesity, diabetes [46]
and systolic blood pressure [11], are included in the pattern 4b, which
is also compatible with the trends observed.
Although some countries depict a variation in mortality rates that
may be compatible with more than one pattern, the model-based clus-
tering yielded essentially the same results when different subsets of the
eligible countries were considered, strengthening the robustness of our
ﬁndings. Belarus, Republic ofMoldova, Russia and Ukrainewere exclud-
ed from our analysis because theirmodel coefﬁcients were substantially
different from those of all the other countries. This, however, reﬂects the
fact that they all have irregular IHD trends (Appendices 1 and 2), which
may be interpreted as a pattern itself, characterized by the highest IHD
ASMR, throughout most of the period under analysis, as well as by an
initial decrease in the IHD ASMR, until 1990, followed by an increase
which is recently becoming less steep. The major socioeconomic
Table 1
Characterization of the patterns of the trends in ischemic heart disease mortality between 1980 and 2010, regarding the estimated age-standardized mortality rates (world standard
population) in 1980, 1995 and 2010, percent changes in rates in the periods 1980–1995 and 1995–2010, and highest rates and corresponding year observed in the whole period, in
the age-group 35+ years, in men and women.
Median
(P25 to P75)
Pattern 1 Pattern 2 Pattern 3 Pattern 4a Pattern 4b
Men
ASMR*
1980 1046.5
(876.1 to 1069.5)
675.9
(639.3 to 707.9)
407.9
(299.0 to 548.1)
252.7
(207.5 to 338.1)
296.2
(178.3 to 337.3)
1995 967.9
(959.7 to 988.7)
399.1
(388.7 to 486.6)
444.1
(356.3 to 578.2)
202.2
(167.4 to 253.5)
219.6
(160.7 to 275.7)
2010 596.4
(474.3 to 720.8)
216.6
(176.6 to 248.5)
249.2
(196.3 to 465.8)
128.1
(98.1 to 142.3)
216.0
(150.6 to 222.8)
Variation in ASMR (%)†
1980–1995 −7.6
(−8.3 to 10.5)
−37.8
(−42.7 to−30.0)
9.5
(−10.2 to 26.5)
−25.9
(−32.9 to−15.0)
−19.5
(−28.9 to−1.1)
1995–2010 −37.8
(−52.0 to−25.5)
−46.6
(−55.4 to−42.1)
−43.2
(−52.6 to−19.1)
−39.5
(−46.6 to−29.4)
−14.1
(−25.9 to 1.2)
ASMR‡
Highest value observed 1158.7
(1061.3 to 1249.4)
689.4
(636.4 to 712.7)
494.2
(400.1 to 616.3)
253.9
(206.4 to 333.9)
260.8
(196.9 to 298.1)
Year of highest value 1993
(1985 to 1994)
1980
(1980 to 1983)
1994
(1991 to 1998)
1980
(1980 to 1985)
1998
(1996 to 2004)
Women
ASMR*
1980 613.6
(597.1 to 631.2)
309.7
(270.8 to 342.1)
302.7
(210.4 to 465.4)
120.6
(91.4 to 161.3)
158.9
(121.8 to 187.7)
1995 541.5
(481.8 to 579.8)
224.7
(193.9 to 255.2)
334.1
(323.2 to 404.1)
106.4
(85.9 to 135.2)
121.8
(93.4 to 134.6)
2010 287.4
(256.1 to 289.3)
117.1
(98.2 to 141.1)
278.3
(230.3 to 342.7)
62.1
(48.6 to 87.9)
108.8
(91.1 to 123.9)
Variation in ASMR (%)†
1980–1995 −14.2
(−21.5 to−2.9)
−32.1
(−34.7 to−19.7)
6.8
(−13.2 to 58.8)
−16.0
(−25.3 to 9.1)
−19.3
(−44.4 to−3.9)
1995–2010 −40.4
(−52.8 to−32.9)
−48.3
(−55.2 to−39.6)
−15.2
(−31.1 to 13.9)
−43.4
(−45.7 to−32.7)
−13.9
(−25.4 to 27.3)
ASMR‡
Highest value observed 671.3
(666.6 to 675.9)
320.6
(300.5 to 347.2)
373.6
(354.7 to 484.5)
135.3
(100.1 to 179.2)
152.7
(121.2 to 165.8)
Year of highest value 1985
(1980 to 1985)
1981
(1980 to 1985)
2000
(1999 to 2005)
1986
(1980 to 1998)
2002
(1999 to 2005)
P25=percentile 25; P75=percentile 75; ASMR=Age standardizedmortality rate. *Estimated ASMR (model predictions); †Percent changes in the estimated ASMR; ‡Observed ASMR, as
obtained from theWorld Health Organization database.
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ized by the absence of sustained health monitoring and policies, with
high levels of tobacco and alcohol consumption and psychosocial stress
due to economic and social instability and could justify the increases ob-
served on IHD ASMR in the early 1990s [46–48].
5. Study limitations
Miscoding and classiﬁcation changes in WHO mortality data could
explain some of the variation over time and between countries. Howev-
er, the adoption of three different revisions of ICD across the period con-
sidered is not expected to compromise the comparability of data within
or between countries [29,30], since the comparability ratios across ICDs
are close to 1 for IHD [31,32]. Still, there are issues of completeness of
death certiﬁcation and data validity thatmayhave varied across settings
and calendar periods, especially in BRICS and some of the middle-
income countries included in our analysis. The data used in our study
might have underestimated the true rates in the settings in which the
number of deaths refers only to part of the population, particularly
when the mortality rates were computed using the UN estimates for
the overall population for each country. Nevertheless, this is not expect-
ed to compromise the comparison of the rates over time. On the other
hand, there are also concerns regarding external validity; in the Repub-
lic of Moldova, Russian Federation and Serbia some geographical re-
gions were excluded from the ofﬁcial mortality statistics, and thetrends presented may not apply equally to the whole country. This ap-
plies to an even larger extent to China, since mortality data covers less
than 10% of the entire population; despite the possible inappropriate-
ness of the generalization to the rest of the country, these data are the
best available for this setting, and still useful.
In conclusion, we propose a framework to deﬁne clusters of coun-
tries with similar patterns of variation in IHDmortality, and a new gen-
eralmodel for thedescription, interpretation andprediction of its trends
worldwide.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcard.2013.11.004.
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